Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B-cell lymphoma
Liu, Zebing, Cai, Ying, Yang, Yu, Li, Anqi, Bi, Rui, Wang, Lisha, Shen, Xiaohan, Wang, Weige, Jia, Yijun, Yu, Baohua, Cao, Bing, Cui, Wenli, Wei, Ping, Zhou, XiaoyanLangue:
english
Journal:
The Journal of Pathology
DOI:
10.1002/path.5108
Date:
June, 2018
Fichier:
PDF, 3.59 MB
english, 2018